GIANT BioSystems
GIANT BioSystems provides an ultra-fast platform that delivers rapid antimicrobial susceptibility results and accelerates drug screening. The company builds a next-generation diagnostic instrument and assay platform for phenotypic antimicrobial susceptibility testing (AST) and high-throughput compound evaluation. Its technology combines rapid phenotypic readouts and automated workflows to shorten time-to-result compared with conventional AST methods. GIANT BioSystems sells laboratory instruments and consumable assays to clinical laboratories, pharmaceutical and biotechnology companies for diagnostic workflows and antibiotic development.
GIANT BioSystems
GIANT BioSystems provides an ultra-fast platform that delivers rapid antimicrobial susceptibility results and accelerates drug screening. The company builds a next-generation diagnostic instrument and assay platform for phenotypic antimicrobial susceptibility testing (AST) and high-throughput compound evaluation. Its technology combines rapid phenotypic readouts and automated workflows to shorten time-to-result compared with conventional AST methods. GIANT BioSystems sells laboratory instruments and consumable assays to clinical laboratories, pharmaceutical and biotechnology companies for diagnostic workflows and antibiotic development.